Lisa Salvatore
0000-0003-3864-0719
Publication & Citation Trends
Most Cited Works
Publications
480 total
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
Cited by 0
Semantic Scholar
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial
Cited by 5
Semantic Scholar
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative
Cited by 1
Semantic Scholar
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated <i>KRAS</i> G12C
Cited by 312
OpenAlex
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial PDF
Cited by 254
OpenAlex
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O<sup>6</sup>-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial PDF
Cited by 123
OpenAlex
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest PDF
Cited by 192
OpenAlex
Research Topics
Colorectal Cancer Treatments and Studies
(298)
Cancer Treatment and Pharmacology
(100)
Gastric Cancer Management and Outcomes
(92)
Genetic factors in colorectal cancer
(81)
Cancer Immunotherapy and Biomarkers
(72)
Frequent Co-Authors
Affiliations
Università Cattolica del Sacro Cuore
AstraZeneca (United Kingdom)
University of Pisa
University of Verona
University of Milan